Enquire Now
Your Name
E-Mail
Mobile Number
Message
Send
About Trident Lifeline
Products
Pharmaceuticals
Tablets
Capsules
Liquid Orals
Oral Dry Powders
Topical Preparations
Dental Preparations
Nutraceuticals
Tablets
Capsules
Liquids
Sachets
Oral Spray
Effervescent Tablets
Global Presence
Investors
Board of Directors
Committees of Board of Directors
Key Managerial Personnel
Disclosure under Regulation 46 of SEBI(LODR), 2015
Stock Exchange Submission
Disclosures
Board Meeting
Policies
Financial Results
Annual Return
Subsidiary Companies
TNS PHARMA PRIVATE LIMITED
Offer Documents
Draft Prospectus
Prospectus
Investor Contacts
Careers
Contact us
info@tridentlifeline.com
|
+91 261 2490224
About Trident Lifeline
Products
Pharmaceuticals
Tablets
Capsules
Liquid Orals
Oral Dry Powders
Topical Preparations
Dental Preparations
Nutraceuticals
Tablets
Capsules
Liquids
Sachets
Oral Spray
Effervescent Tablets
Global Presence
Investors
Board of Directors
Committees of Board of Directors
Key Managerial Personnel
Disclosure under Regulation 46
of SEBI(LODR), 2015
Stock Exchange Submission
Disclosures
Board Meeting
Policies
Financial Results
Annual Return
Subsidiary Companies
TNS PHARMA PRIVATE LIMITED
Offer Documents
Draft Prospectus
Prospectus
Investor Contacts
Careers
Contact us
Disclosures
Investors
Board of Directors
Committees of Board of Directors
KEY MANAGERIAL PERSONNEL
POLICIES
DISCLOSURES
BOARD MEETING
DRAFT PROSPECTUS
PROSPECTUS
TNS PHARMA PRIVATE LIMITED
ANNUAL RETURN
Investor Contacts
2023-2024
2022-2023
Earnings Presentation_Q4FY23
Newspaper Publication_Financial Results_09.05.2023
Non-Applicability of Regulation 23(9) of SEBI(LODR), 2015
Certificate under Reg 40(9)-11.04.2023
SHP_03.2023-11.04.2023
LC_DISCLOSURE-11.04.2023
Certificate under Reg 7(3)-10.04.2023
CG_NON APPLICABILITY-08.04.2023
Statement of Deviation_031.03.2023
CERTIFICATE UNDER 74(5)_31.03.2023
Reconciliation of Share Capital Audit Report_31.03.2023
IG_31.03.2023
Intimation of Closure of Trading Window- 30.03.2023
Disclosure under Reg 29(2) of SEBI SAST, 2011_02.02.2023
Disclosure under Reg 29(2) of SEBI SAST, 2011_01.02.2023
Disclosure under Reg 29(2) of SEBI SAST, 2011_25.01.2023
Disclosure under Reg 29 (1) and (2) of SEBI(SAST), 2011_24.01.2023
Inadvertent Trade by Designated Person
Earning Presentation_Q3FY23
Disclosure under Reg 29 (1) and (2) of SEBI(SAST), 2011_23.01.2023
Disclosure under Regulation 29(2) and (3) of SEBI (SAST), 2011_21.01.2023
Newspaper Publication-Financial Results_18.01.2023
STATEMENT OF DEVIATION_31.12.2022
Certificate 74(5)_31.12.2022
Reconciliation of Share Capital Audit_31.12.2022
Submission of Consolidated Limited Review Report for the quarter ended 31.12.2022
Non-Applicability of Corporate Governance Provisions_31.12.2022
IG_31.12.2022
SHP_31.12.2022
Intimation of Closure of Trading Window-30.12.2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 27-12-2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 30-11-2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 25-11-2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 24-11-2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 17-11-2022
Intimation of Closure of Trading Window - 17-10-2022
SHP_04.10.2022
Intimation of Acquisition of TNS Pharma Pvt. Ltd.
Earnings Presentation_Q4FY23
